Get in touch

info@obpharm.com

Follow us

OBPharm

Transforming cardiometabolic health through precision science

Book a consultation

“Chronic diseases are not isolated; cardiovascular, kidney, and metabolic health are deeply interwoven, demanding a holistic approach."

Why us

At OBPharm, we are redefining healthcare with a unique focus on cardiovascular, kidney, and metabolic (CKM) health. Our commitment to innovation, combined with cutting-edge biomolecular engineering and artificial intelligence, allows us to develop precision therapies that target the root causes of complex diseases. By choosing OBPharm, you’re partnering with a team that is deeply invested in advancing science to improve lives. Our collaborative approach includes partnerships with leading academic institutions and industry innovators, ensuring that our solutions are informed by the latest research and technological advancements. With a relentless dedication to quality, regulatory compliance, and patient-centricity, OBPharm is the trusted choice for impactful, reliable, and future-focused healthcare solutions.

ObPharm. in numbers

10+ Decades

Collective experience across pharmaceutical R&D, academia, and cutting-edge medical innovation across our founding members.

300+ Billion

Annual TAM across cardiovascular, kidney and metabolic disorders, propelled by the rising burden of chronic diseases and increasing healthcare expenditures.

50,000+ citations

Our science has been published in premier journals such as PNAS, Cell, Circulation, and Nature.

Get in Touch

We'd love to hear from you

Book a consultation

“"Antibodies are nature’s precision tools, capable of targeting specific molecules with incredible accuracy.""

OBPharm LLC

News & Updates

The CKM Axis: Understanding the Interconnected Pathways of Cardiovascular, Kidney, and Metabolic Health

By test • April 1, 2021
Exploring how cardiovascular, kidney, and metabolic systems are interconnected and why a holistic approach to treatment is essential.

Harnessing Biomolecular Engineering and AI in Drug Discovery: A New Frontier in Precision Medicine

By test • April 1, 2021
The field of medicine is undergoing a revolution. Precision medicine, which aims to tailor treatments to individual patients rather than taking a one-size-fits-all approach, is transforming how we approach complex diseases. At OBPharm, we are at the forefront of this transformation, leveraging biomolecular engineering and artificial intelligence (AI) to discover and develop therapies that target diseases at their molecular roots with unprecedented accuracy.

The Future of Cardiometabolic Health: Trends and Innovations to Watch

By test • April 1, 2021
The rise of cardiovascular, kidney, and metabolic diseases has brought cardiometabolic health to the forefront of modern medicine. At OBPharm, we are committed to pioneering the next wave of innovations that will reshape how we approach these interconnected health challenges. Here, we explore the latest trends and breakthroughs in cardiometabolic health and the exciting possibilities they hold for the future.
Share by: